Secor Capital Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,131	Closed	-$227K	–	561
2018 Q3	$227K	Sell	9,131 -9,692	-51%	-$241K	0.02%	335
2018 Q2	$517K	Buy	+18,823	New	+$517K	0.04%	333
2014 Q4	–	Sell	-22,175	Closed	-$429K	–	493
2014 Q3	$429K	Buy	+22,175	New	+$429K	0.24%	154